scholarly article | Q13442814 |
P50 | author | Michael R. Betts | Q88295419 |
P2093 | author name string | Carolina Pombo | |
Morgan A. Reuter | |||
P2860 | cites work | Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP | Q22009938 |
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts | Q22251065 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 | ||
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes | Q24321949 | ||
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function | Q24600313 | ||
Role of PD-1 in HIV pathogenesis and as target for therapy | Q24634293 | ||
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 | ||
Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV) | Q24682863 | ||
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections | Q36915902 | ||
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens | Q36954734 | ||
Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection | Q37078512 | ||
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control | Q37169129 | ||
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression | Q37678595 | ||
Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation | Q37764002 | ||
The elusive identity of T follicular helper cells | Q37784588 | ||
Pathogenic Mechanisms of HIV Disease | Q37804860 | ||
Mechanism of T cell exhaustion in a chronic environment | Q37869551 | ||
The influence of HIV on CD127 expression and its potential implications for IL-7 therapy | Q37994025 | ||
Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. | Q38319280 | ||
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients. | Q39214135 | ||
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection | Q39561892 | ||
Molecular basis of the dual functions of 2B4 (CD244). | Q39975619 | ||
A TH1-->TH2 switch is a critical step in the etiology of HIV infection | Q40709038 | ||
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells | Q40757721 | ||
IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). | Q40977801 | ||
IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression | Q41025968 | ||
Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells | Q41135083 | ||
Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells | Q41208701 | ||
Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. | Q41492588 | ||
Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells | Q42251342 | ||
IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses | Q42453465 | ||
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. | Q42739331 | ||
Cytokines alter production of HIV-1 from primary mononuclear phagocytes | Q44548244 | ||
Germinal centre CD4+ T cells are an important site of HIV replication in vivo. | Q44588643 | ||
IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine | Q44624519 | ||
Interleukin-10 determines viral clearance or persistence in vivo | Q27486832 | ||
Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness | Q27487966 | ||
Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections | Q27488278 | ||
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
Control of HIV-1 replication in elite suppressors | Q28278044 | ||
T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt | Q28589692 | ||
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults | Q28740321 | ||
Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells | Q28754733 | ||
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial | Q28972526 | ||
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 | ||
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major | Q29619125 | ||
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity | Q29619700 | ||
T cell exhaustion | Q29620463 | ||
Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time | Q33354070 | ||
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control | Q33594461 | ||
Interleukin-7: physiological roles and mechanisms of action | Q33668794 | ||
T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. | Q33709760 | ||
IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection | Q33733943 | ||
Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression | Q33747965 | ||
Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation | Q33761406 | ||
Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation | Q33829736 | ||
Interleukin-2 therapy in patients with HIV infection | Q33847543 | ||
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone | Q33847737 | ||
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection | Q33869806 | ||
HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
Phenotype, effector function, and tissue localization of PD-1-expressing human follicular helper T cell subsets | Q34018408 | ||
Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion | Q34072842 | ||
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses | Q36229406 | ||
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals | Q36230977 | ||
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid | Q36276936 | ||
CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major | Q36362926 | ||
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. | Q36368095 | ||
Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15 | Q36369750 | ||
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells | Q36369770 | ||
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity | Q36371562 | ||
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. | Q36402501 | ||
Germinal-center organization and cellular dynamics | Q36459345 | ||
Th17: the third member of the effector T cell trilogy | Q36528977 | ||
Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells | Q36666548 | ||
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle | Q36691272 | ||
Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251. | Q36808324 | ||
Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery | Q36825473 | ||
Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. | Q36845770 | ||
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis | Q34118839 | ||
HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment | Q34140484 | ||
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat | Q34295016 | ||
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells | Q34417483 | ||
Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV | Q34514374 | ||
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction | Q34570127 | ||
Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10 | Q34683647 | ||
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover | Q34692601 | ||
2B4+ CD8+ T cells play an inhibitory role against constrained HIV epitopes | Q34714101 | ||
A therapeutic dendritic cell-based vaccine for HIV-1 infection | Q34764392 | ||
A fundamental role for interleukin-21 in the generation of T follicular helper cells | Q34792475 | ||
Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression | Q34870550 | ||
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. | Q34891171 | ||
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist | Q34900183 | ||
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection | Q35001605 | ||
Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control | Q35022846 | ||
Responsiveness of HIV-specific CD4 T cells to PD-1 blockade | Q35140996 | ||
Biological functions of tumor necrosis factor cytokines and their receptors | Q35145609 | ||
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers | Q35363011 | ||
Perforin and the granule exocytosis cytotoxicity pathway | Q35538157 | ||
Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages | Q35600426 | ||
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals | Q35652583 | ||
Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replic | Q35677099 | ||
DCs and NK cells: critical effectors in the immune response to HIV-1. | Q35752667 | ||
Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load | Q35784804 | ||
Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants | Q35826378 | ||
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals | Q35844592 | ||
A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses | Q35871793 | ||
Natural regulatory T cells in infectious disease | Q36078051 | ||
Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression | Q36081615 | ||
CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes | Q36086676 | ||
Understanding the benign nature of SIV infection in natural hosts | Q36099429 | ||
Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection | Q45223808 | ||
Suppressive activity of regulatory T cells correlates with high CD4(+) T-cell counts and low T-cell activation during chronic simian immunodeficiency virus infection | Q45370466 | ||
Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection | Q45370561 | ||
Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection | Q45405292 | ||
Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees | Q45407910 | ||
Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. | Q45723591 | ||
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons | Q45764071 | ||
Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes | Q45772177 | ||
Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection | Q45784847 | ||
Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication | Q45786225 | ||
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. | Q45955459 | ||
The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment | Q46445396 | ||
IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation | Q46610378 | ||
Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. | Q46902933 | ||
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease | Q46950134 | ||
Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice | Q47805056 | ||
Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia | Q48023288 | ||
HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. | Q51051553 | ||
Molecular signature of CD8+ T cell exhaustion during chronic viral infection. | Q51970485 | ||
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. | Q51977322 | ||
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. | Q51991024 | ||
Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. | Q52011176 | ||
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. | Q52844166 | ||
HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. | Q54524214 | ||
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count | Q56334717 | ||
Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control | Q56899705 | ||
Elite control of HIV infection: implications for vaccine design | Q56994404 | ||
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques | Q57081543 | ||
IL-15 enhances survival and function of HIV-specific CD8+ T cells | Q58479905 | ||
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis | Q58779416 | ||
CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains | Q60199574 | ||
Seventeen-colour flow cytometry: unravelling the immune system | Q62577376 | ||
Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes | Q67543297 | ||
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor | Q70128457 | ||
Interferon-gamma inhibits HIV-induced invasiveness of monocytes | Q71587224 | ||
Regulation of HIV production by blood mononuclear cells from HIV-infected donors: I. Lack of correlation between HIV-1 production and T cell activation | Q72798405 | ||
A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis | Q73196828 | ||
Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants | Q73262403 | ||
Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants | Q73636717 | ||
Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo | Q73669406 | ||
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients | Q74330262 | ||
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors | Q78342521 | ||
Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients--effects of antiretroviral therapy | Q79817109 | ||
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro | Q80104585 | ||
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator | Q80487900 | ||
The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors | Q82644038 | ||
Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway | Q82855791 | ||
P433 | issue | 4-5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pathogenesis | Q372016 |
vaccine development | Q27133094 | ||
P304 | page(s) | 181-91 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
P1476 | title | Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines | |
P478 | volume | 23 |
Q90626517 | Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection |
Q40457741 | Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy. |
Q53701787 | Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi. |
Q35192275 | Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens |
Q40053061 | Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure. |
Q36888298 | Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection |
Q36706314 | HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis-Specific CD4+ T Cells. |
Q44519131 | HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127. |
Q35120242 | Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway |
Q41160760 | Immunoendocrine interactions during HIV-TB coinfection: implications for the design of new adjuvant therapies. |
Q36032171 | Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice |
Q34608495 | Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivo |
Q57285031 | P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model |
Q36026644 | Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection |
Q36294727 | Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection |
Q92883492 | Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology |
Q93211764 | Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis |
Q36462210 | The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection |
Q38768132 | Thymosin alpha 1 and HIV-1: recent advances and future perspectives |
Q34780332 | Vaginal microbiota and its role in HIV transmission and infection |
Q38832958 | Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells |
Search more.